Manual of Hypertension of the European Society of Hypertension, Third Edition

Description:

The Manual of Hypertension of the European Society of Hypertension reflects emerging concepts that have the potential to impact diagnostic and therapeutic approaches to hypertension. Updating all material, this new edition also delves into a number of areas that have received heightened interest in recent years or have become a matter of debate due to the controversial interpretation of the available data. FEATURES Reflects emerging concepts impacting diagnostic and therapeutic approaches Explores background, history, epidemiology, and risk factors Describes pharmacological, nonpharmacological, and medical treatments Examines hypertension in special populations and treatment

Table of Contents:

SECTION I Background and Epidemiology

1. History of the European Society of Hypertension: Past, Present and Future

2. Hypertension as a Cardiovascular Risk Factor

3. Hypertension and the Kidney

4. Blood Pressure Control in Europe and Elsewhere

5. Socioeconomic Determinants

SECTION II Etiological and Pathophysiological Aspects

6. Hemodynamic Patterns in Hypertension

7. Genetic Basis of Blood Pressure and Hypertension

8. Oxidative Stress, Inflammation, Immune System and Hypertension

9. Sodium and Potassium

10. Structural Cardiovascular Changes in Hypertension

11. Early Vascular Ageing

12. Autonomic Dysfunction

13. The Renin–Angiotensin–Aldosterone System

14. Stress, Stress Reduction and Hypertension: An Updated Review

SECTION III Associated Risk Factors: Pathogenetic Role and Risk Modification

15. Heart Rate as a Cardiovascular Risk Factor in Hypertension

16. Obesity and Obstructive Sleep Apnoea

17. The Metabolic Syndrome in Hypertension

18. Psychosocial Risk Factors, Airborne Pollution, Hypertension and Cardiovascular Diseases

19. Serum Uric Acid, Blood Pressure and Hypertension

20. Dyslipidaemia in Hypertension

SECTION IV Blood Pressure Measurements

21. Old and New Office Blood Pressure Measurement Approaches

22. Pulse Pressure

23. Central Blood Pressure

24. Ambulatory Blood Pressure Measurement

25. Home Blood Pressure

26. Day-Night Related Events: Nighttime Blood Pressure Fall and Morning Blood Pressure Rise

27. Short-Term Blood Pressure Variability

28. Exercise Blood Pressure: The Prognostic Impact of Exercise Systolic Blood Pressure

SECTION V Organ Damage-Measurement/Clinical Value

29. Cardiac Damage from Left Ventricular Hypertrophy to Heart Failure

30. Structural and Functional Aspects of Brain Damage

31. Large Artery Damage: Measurement and Clinical Importance

32. Microcirculation

33. Endothelial Damage

34. Retinal Changes

SECTION VI Integrated Diagnostic Aspects

35. The Integrated Diagnostic Approach in General Medicine

36. Management of Hypertension by the Hypertension Specialist and the Hypertension Excellence Centres

SECTION VII Therapeutic Aspects

37. Non-Pharmacological Interventions

38. The Protective Cardiovascular Effects of Antihypertensive Treatment

39. The Nephroprotective Effect of Antihypertensive Treatment

40. Antihypertensive Drug Classes

41. Single-Pill Combination Treatments in Hypertension

42. The J-Curve Phenomenon

43. A Polypill for Global Cardiovascular Prevention: Current Data and Future Perspectives

44. Managing Adverse Effects and Drug Intolerance

45. Adherence to Treatment in Hypertension

46. Residual Risk in Treated Patients

SECTION VIII Special Conditions

47. Ethnic Factors in Hypertension

48. Resistant Hypertension: Medical Treatment

49. Interventional Therapies for Essential Hypertension

50. Atrial Fibrillation and Arterial Hypertension

51. The Diabetic/Obese Hypertensive Patient (Including Metabolic Syndrome)

52. Hypertension in Children and Adolescents

53. Hypertensive Emergencies and Urgencies

54. Hypertension Associated with Peripheral Artery Disease

55. Hypertension in Pregnancy

56. Drug-Induced Hypertension

57. Hypertension in Patients with Advanced Chronic Kidney Disease

58. Blood Pressure Management in Acute Stroke

59. Blood Pressure Management in the Chronic Post-Stroke Phase

60. The Post-Transplant Patient with Hypertension

SECTION IX Secondary Hypertension: Diagnosis and Treatment

61. Renovascular Hypertension

62. Primary Aldosteronism

63. Pheochromocytoma and Paraganglioma

SECTION X Additional Aspects

64. Follow-Up of the Hypertensive Patient

65. 2018 ESC/ESH Hypertension Guidelines

Index